-
1دورية أكاديمية
المؤلفون: Konduracka E; Department of Coronary Disease, Jagiellonian University School of Medicine, Krakow, Poland. konduracka27@interia.eu, Galicka-Latala D, Cieslik G, Rostoff P, Fedak D, Sieradzki J, Naskalski J, Piwowarska W
المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2008 Sep; Vol. 10 (9), pp. 719-25. Date of Electronic Publication: 2007 Oct 15.
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
مواضيع طبية MeSH: Coronary Artery Disease/*prevention & control , Diabetes Mellitus, Type 1/*drug therapy , Diabetic Angiopathies/*prevention & control , Endothelium, Vascular/*drug effects , Heptanoic Acids/*therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use , Pyrroles/*therapeutic use, Adult ; Atorvastatin ; Brachial Artery/drug effects ; Brachial Artery/physiopathology ; Coronary Artery Disease/physiopathology ; Diabetes Mellitus, Type 1/diet therapy ; Diabetes Mellitus, Type 1/physiopathology ; Endothelium, Vascular/physiopathology ; Female ; Humans ; Male ; Middle Aged ; Plasminogen Activator Inhibitor 1/blood ; Vasodilation/physiology ; von Willebrand Factor/metabolism